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Due to the high prevalence of illicit drug use and subsequent costs to society, 
researchers have focused on potential mechanisms underlying continued substance 
use and dependence. One mechanism of interest is the hypothalamic-pituitary-adrenal 
(HPA) axis and its primary hormone, cortisol. Chronic substance use is associated 
with elevated basal cortisol concentrations and a blunted cortisol response to stress 
which has been shown to predict substance use outcomes. However, little is known 
about the specific conditions under which drug users display a dysregulated cortisol 
response to stress. Therefore, the current study compared HPA axis response to two 
different psychological stressors among a sample of cocaine dependent individuals. 
Results indicated no significant differences in cortisol response across the three 
conditions. Future researchers should conduct larger scale studies with carefully 
matched healthy non-drug using participants to determine whether the absence of a 
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Chapter 1: Introduction 
1.1 Stress and Addiction 
Illicit substance use is a pervasive and costly problem in the United States. 
According to the 2006 National Survey on Drug Use and Health, 22.6 million people 
aged 12 and older met criteria for substance dependence or abuse in the past year 
(SAMHSA, 2007). Of those, 7.0 million people were dependent on or abused illicit 
substances, with 1.7 million meeting criteria for dependence or abuse of cocaine in 
particular (SAMHSA, 2007), making cocaine the second most prevalent illicit drug used 
in the United States (SAMHSA, 2008). Besides being highly prevalent, illicit substance 
use disorders, and cocaine use disorders in particular, come with dire public health and 
economic consequences including increases in unemployment (Luck, Elifson, & Sterk, 
2004), homelessness (e.g. Nyamathi, Wenzel, Keenan., 1999), crime (e.g. Friedman, 
Glassman, & Terras, 2001), and transmission of sexually transmitted diseases (STDs) 
including HIV (e.g., Avants, Marcotte, Arnold, & Margolin, 2003; Ensminger, Anthony, 
& McCord, 1997; Miller & Neaigus, 2002).  
Due to the high prevalence of illicit drug use and subsequent costs to society, it is 
imperative to gain a comprehensive understanding of the mechanisms involved in the 
initiation, maintenance, and relapse to drug addiction. A majority of theories of addiction 
have emphasized the role of acute and chronic stress in substance use and relapse 
(Conger, 1956; Khantzian, 1985; Koob & LeMoal, 1997, 2001, 2008; Levanthal & 
Cleary, 1980; Marlatt & Gordan, 1985; Russel & Mehrabian, 1975; Sher & Levenson, 
1982; Shiffman, 1982; Solomon, 1977; Tomkins, 1966; Wikler, 1948; Wills & Shiffman, 




relapse prevention model suggests that in addition to bio-psychosocial risk factors such as 
parental substance use, peer pressure, and positive expectancies regarding the benefits of 
substance use, poor coping resources in the face of stress serve to increase one’s 
vulnerability to addiction. Further, the stress-coping model of addiction suggests that 
addictive substances function not only to increase positive affect but to decrease negative 
affect as well, thereby serving as an effective, yet maladaptive coping strategy (Shiffman, 
1982; Wills & Shiffman, 1985). In fact, a number of models addressing the underlying 
mechanisms responsible for addiction and relapse to drug use have centered around 
negative reinforcement processes (Baker et al., 2004; Khantzian, 1985; Solomon, 1977; 
Wikler, 1948), which collectively emphasized that the motivational basis of addictive 
drug use is the reduction or avoidance of aversive internal states, including stress. 
A number of studies have provided evidence for the role of psychological stress 
and affective distress in substance use initiation, progression to addiction, and relapse. 
For example, exposure to early adversity such as emotional, physical, and sexual abuse in 
childhood is associated with increased risk for addiction and with early initiation of 
substance use (Bensley et al., 1999; Dembo et al., 1988; Harrison et al., 1997; Widom et 
al., 1999). Similarly, frequency of trauma history is significantly greater among drug-
dependent individuals (especially in women) than among non-drug users (Najavits et al., 
1998). Additionally, high levels of social and environmental stress have been associated 
with a rapid progression in tobacco, marijuana, and alcohol use (Kaplan and Johnson, 
1992; Wills et al., 1996). Further, direct exposure to an acute stressor has been shown to 
increase desire to smoke and the subsequent number and duration of puffs in smokers 




O’Malley, 1999). Finally, self-reported stress-induced cocaine craving has been shown to 
predict cocaine relapse following release from inpatient treatment (Sinha et al., 2006). 
Specific to relapse, not only do external stressors pose a risk to individuals in the 
early stages of abstinence, but the withdrawal symptoms themselves can serve as 
significant stressors. Studies show that negative affect often arises in addicted individuals 
as a result of withdrawal syndromes that cause feelings of irritability, anxiety, stress, and 
depression (Baker, Japuntich, Hogle, McCarthy, Curtin, 2006), and the severity of these 
withdrawal symptoms predict treatment outcome and relapse among smokers, cocaine 
addicts, heroin dependent individuals, and alcoholics (Carroll, Power, Bryant, & 
Rounsaville,1993; Doherty, Kinnunen, Militello, & Garvey, 1995; McLellan, Luborsky, 
Woody, O’Brien, & Druley, 1983; Mulvaney, Alterman, Boardman, & Kampman, 1999; 
Tennant, Shannon, Nork, Sagherian, & Berman, 1991). For example, findings from 
Miller, Westerberg, Harris, & Tonigan (1996) indicate that affective distress, specifically 
depression and anxiety, is a significant predictor of 6-month, post-treatment substance 
use outcomes. Second, recent prospective studies have shown that affective distress at the 
beginning of treatment and after quitting predicts poor outcome (El-Geili & Bashir, 2005; 
Hser, Huang, & Teruya, 2003; McMahon, 2001). Third, a number of studies have 
consistently reported that relapse to drug use often occurs in situations involving negative 
moods such as anxiety, anger, and depression (Brandon, Tiffany, Obremski, & Baker, 
1990; El-Geili & Bashir, 2005; Litman, Stapleton, Oppenheim, & Peleg, 1983; Marlatt & 
Gordon, 1985; Tate, Brown, & Unrod, 2004).  
The above research supports existing theories of addiction that emphasize the role 




However, the above mentioned studies rely on self-report methodology, which is limited 
by the ability of participants to recall events and emotions that may have occurred weeks 
or months ago, as well as the quality of participant insight into their own emotions and 
behavior. Moreover, not every individual relapses to drug use in response to affective 
distress. Therefore, researchers have turned to biopsychological mechanisms underlying 
the stress response in order to further their understanding of the relationship between 
stress and deleterious substance use treatment outcomes. One such biopsychological 
mechanism of interest is the hypothalamic-pituitary-adrenal (HPA) axis. 
 
1.2 Hypothalamic-Pituitary-Adrenal (HPA) Axis: An Overview 
 The HPA axis, which controls the secretion of hormones from the pituitary gland 
and adrenal cortex, plays a central role in mediating the body’s response to stress and is 
extremely sensitive to inputs from the limbic system and prefrontal cortex, two brain 
areas that are important in modulating reinforcement and motivational processes (Li & 
Sinha, 2008). The anatomical structures of the HPA axis are localized in the 
paraventricular nucleus (PVN) of the hypothalamus, the anterior lobe of the pituitary 
gland, and the adrenal cortex (Smith & Vale, 2006). In response to stress, the HPA axis is 
activated when corticotrophin-releasing factor (CRF), the principle regulator of HPA axis 
functioning, is released by neurons in the PVN (Smith & Vale, 2006). CRF then binds to 
receptors in the anterior pituitary where it stimulates the secretion of adrenocorticotropin 
hormone (ACTH) (Charmandari, Tsigos, & Chrousos, 2005; Smith & Vale, 2006). 
ACTH then targets the adrenal cortex where it stimulates the synthesis and release of 




fasciculate (Smith & Vale, 2006). Glucocorticoids are the final effectors in the HPA axis, 
regulating physiological changes in response to stress through ubiquitiously distributed 
intracellular receptors throughout the body (Bamberger, Schulte, & Chrousos, 1996; Kino 
& Chrousos, 2001; Munck, Guyre, & Holbrook, 1984). Glucocorticoids also play an 
important role in the termination of the stress response by providing negative feedback to 
inhibit the further secretion of CRF and ACTH, thereby limiting the duration of total 
exposure of the organism to the catabolic, lipogenic, antireproductive, and 
immunosuppressive effects of these glucocorticoids (Charmandari, Tsigos, & Chrousos, 
2005). In the absence of any provocation, glucocorticoid secretion tends to follow a 
circadian rhythm, with concentrations peaking in the morning 20-45 minutes after waking 
and subsequently declining throughout the course of the day (Clow et al., 2004).  
 
1.3 The HPA Axis and Addiction: Evidence from Animal Models 
Findings from animal models of addiction provide substantial evidence for the 
role of HPA axis functioning in addiction processes. In terms of acquisition of drug self-
administration, rats who respond to stressful stimuli with prolonged secretion of 
corticosterone have shown a higher tendency to self-administer psychostimulants, and 
among rats that previously did not self-administer, injections of exogenous corticosterone 
have been shown to facilitate the acquisition of psychostimulant self-administration 
(Piazza et al., 1991). Additionally, stress-induced increases in corticosterone have been 
shown to positively correlate with increased self-administration of low doses of cocaine 
following a stressor, suggesting that rats become more sensitive to the reinforcing effects 




Guerin, 1996a). Further, increased self-administration of low doses of cocaine can be 
induced by pretreatment with exogenous corticosteroid injections (Mantsch et al., 1998), 
while adrenalectomy (which significantly reduces plasma corticosterone concentrations) 
prevents the acquisition of cocaine self-administration at any dose (Goeders & Guerin, 
1996b). As such, animal models of cocaine initiation suggest that corticosterone both 
increases the reinforcing effects of psychostimulants, and is necessary for the acquisition 
of self-administration to occur. 
 As animals progress from acute to chronic administration of drugs of abuse, 
progressive changes in HPA axis functioning have been observed. Specifically, acute 
administration of drugs is associated with increased activation in HPA axis functioning 
during the acquisition phase (e.g., Goeders et al., 1997), while HPA activation becomes 
blunted with repeated drug administration (e.g., Goeders, 2002). Dysregulation is also 
observed following cessation from chronic drug administration, as HPA hormones 
including CRF, adrenocorticotropic hormone, and corticosterone are elevated in rats 
following acute withdrawal across drug classes (see Koob & LeMoal, 2008b). Further, 
CRF antagonists (which reduce HPA activation) have been shown to reverse the anxiety-
like behaviors and increased drug self-administration that are observed in rats during 
acute cocaine withdrawal (Specio et al., 2008), and to prevent stress-induced 
reinstatement of drug seeking among cocaine dependent rats following extinction 
procedures (Erb, Shaham, & Stewart, 1998). Thus, findings from animal models of 
dependence and withdrawal suggest that the HPA axis becomes dysregulated over the 
course of addiction, and that CRF (the primary activator of the HPA axis) plays a critical 




addiction have provided compelling evidence for the role of HPA axis functioning in 
addictive behavior, and have formed the basis of current neurobiological models of 
addiction. 
 
1.4 The Neurobiology of Addiction: The Role of HPA Dysregulation 
Neurobiological models of drug addiction, largely stemming from animal 
findings, hypothesize that dysregulated HPA axis functioning contributes to a state of 
chronic deviation of the regulatory system from its normal operating level, resulting in 
the establishment of a “negative affect” or psychologically distressed state during 
abstinence in addicts which increases the reinforcing effects of drugs and thus 
vulnerability to relapse (Koob, 2009; Koob & Le Moal, 2001, 2008). Specifically, when 
reward pathways (i.e. the mesocorticolimbic dopamine system) are activated by drug 
administration, opposing antireward systems (i.e. brain stress circuits involved in CRF 
secretion) are recruited to limit reward function and maintain homeostasis. Over the 
course of chronic drug administration, neuroadaptive changes occur in response to the 
excessive utilization of brain reward systems, including decreased activation of brain 
reward systems and increased activation in opposing brain stress circuits. This 
combination of depressed reward circuits and elevated antireward circuits is hypothesized 
to be the driving force motivating continued drug seeking behavior (Koob & Le Moal, 
2008). Further, elevated activation of brain stress systems is hypothesized to reduce an 
individual’s ability to adapt or cope with additional stressors during abstinence, thereby 




In addition to dysregulation in basal reward and antireward system functioning, 
the sequence of events associated with HPA reactivity to stress is also believed to be a 
key mechanism mediating the relationship between stress and increased drug use (Sinha, 
2001, 2008). Specifically, CRF activation and subsequent release of ACTH and 
glucocorticoids in response to stress is associated with increases in dopaminergic 
neurotransmission in mesolimbic regions (Dunn, 1988; Kalivas & Duffy, 1989; Oswald 
et al., 2005; Piazza & Le Moal, 1996; Prasad, Sorg, Ulibarri, & Kalivas, 1995; Thierry, 
Tassin, Blanc, & Glowinski, 1976). Dopaminergic functioning in these regions is 
believed to be a key component of the brain reward systems, critical for the reinforcing 
properties of drugs of abuse (Di Chiara & Imperato, 1988; Koob & Le Moal, 1997; 
Roberts, Koob, Klonoff, & Fibiger, 1980; Taylor & Robbins, 1984). Thus, in chronic 
substance users who are already suffering from altered reward and antireward system 
functioning, dopaminergic activation in times of stress may serve to further enhance the 
motivational salience of illicit drug use, thereby providing the neural substrate by which 
stress may enhance the reinforcing effects of drugs and increase self-administration 
(Sinha, 2001, 2008). 
Taken together, neurobiological models suggest that chronic drug use is 
associated with neuroadaptive changes, including decreased reward system activation and 
increased antireward system functioning, which may contribute to the affective distress 
experienced by addicts during abstinence, and that these changes may further limit one’s 
ability to adapt or cope in the face of additional stressors during early abstinence. 
Additionally, research shows that HPA axis reactivity to stress is associated with 




effects of drugs in times of stress and increasing the risk of stress-induced relapse to 
substance use. Therefore, a deeper understanding of HPA axis stress reactivity during 
abstinence from chronic drug use, including a more thorough characterization of the 
specific types of psychological stressors that are associated with a dysregulated HPA axis 
response to stress, is critical given that individuals in early recovery are likely to face a 
wide variety of psychosocial stressors that could trigger a dysregulated HPA axis 
response and potentially increase the risk of relapse, including reconnecting with family 
and friends, looking for employment, and finding housing. As such, determining whether 
specific stressors lead to different HPA axis responses could be useful for clarifying the 
specific conditions that may contribute to stress-induced relapse. 
 
1.5 Studying HPA Reactivity to Stress in the Laboratory 
 Given the convergent evidence from animal models for the role of HPA axis 
dysfunction in drug use acquisition and stress induced relapse, researchers have placed a 
strong emphasis on the need to develop valid and reliable laboratory paradigms that can 
be used to examine these mechanisms among humans and in the clinical context (e.g., 
Sinha, 2009). There are a number of factors that one must consider when modeling and 
studying stress in the laboratory, particularly among chronic drug users. Sinha (2009) 
argues that “ecological relevance of the provocation method is among the more important 
of these factors” (p. 86). Early stress researchers argued that the biological stress 
response, including HPA axis activation, is nonspecific in the sense that all stressors, 
regardless of type, were believed to elicit the same physiological reaction (Selye, 1956). 




for stressor-specific pathways to cortisol activation, identifying differential neurological 
correlates and downstream physiological effects leading to activation of an HPA axis 
response depending on the stressor type (Dickerson & Kemeny, 2004; Sawchenko & 
Ericsson, 2000). Less is known, however, about the specific impact of different types of 
stressors on physiological response, including HPA axis activation, among humans. 
Therefore, if researchers hope to draw inferences about real-world stress responses based 
on their laboratory findings, such as making predictions about stress-induced relapse to 
drug use, it is important to utilize stressors that are ecologically relevant to real-world 
experiences.  
Another factor to consider is the available evidence suggesting widespread 
individual differences in what is considered “stressful” (Cohen, Kessler, & Gordon, 1995; 
Lazarus, 1999). Psychological stressors influence physiological processes by activating 
components of the central nervous system, including the prefrontal cortex and the limbic 
system, that are associated with cognitive appraisals and affective responses (Dickerson 
& Kemeny, 2004). The extensive connections between the prefrontal cortex, limbic 
structures, and the hypothalamus serve as the primary pathway for activating and 
regulating the HPA axis (see Dickerson & Kemeny, 2004; Feldman, Conforti, & 
Weidenfeld, 1995; Lovallo, 1997 for reviews). These same neural pathways have been 
implicated in substance use vulnerability, drug craving, and stress- and drug cue-induced 
relapse (Li & Sinha, 2008). Thus, individual differences in neural functioning in response 
to stress in these regions, and subsequent variation in cognitive and affective appraisal 
processes, can contribute to substantial variation in the magnitude of HPA axis response 




induced relapse (Li & Sinha, 2008). These individual differences become even more 
important to consider when attempting to differentiate HPA responses among a clinical 
sample, such as chronic substance users, from the “normal” responses among healthy 
non-drug users (Sinha, 2009). That is, between-group differences in HPA axis response 
to a task may be driven by differential perceptions of the “stressfulness” of the paradigm, 
rather than by the between-group variable of interest (i.e., chronic drug use). Therefore, 
use of personalized stressors that are developed on an individualized basis may be useful 
to insure that the stressor will induce a reliable and robust HPA axis response in the 
laboratory. Additionally, it is important to further account for individual differences in 
perceived stressfulness by including sensitive measures of affect to assess the 
effectiveness of the paradigm to induce a psychologically distressed state across 
participants. 
Despite individual differences in the appraisal and perception of stressful 
scenarios, two specific components have been identified as being important for reliably 
inducing the largest HPA axis responses, as well as the longest recovery periods 
following stress exposure. Specifically, a meta-analysis of 208 laboratory studies of HPA 
axis reactivity to acute laboratory stressors revealed that cortisol responses were most 
reliably induced when the stress paradigm included an element of uncontrollability or 
social-evaluative threat (i.e., a risk of being negatively judged by others) (Dickerson & 
Kemeny, 2004). Laboratory stressors that included elements of both uncontrollability and 
social-evaluative threat elicited the largest cortisol responses of all. Although the meta-
analysis excluded studies of HPA axis functioning among clinical samples, the robust 




studies examining HPA axis reactivity among pathological samples, such as chronic 
substance users, should include laboratory stressors with these two characteristics in 
order to maximize the likelihood that the stressor will be perceived as “stressful” and will 
induce an HPA axis response that deviates from normal basal functioning.   
Finally, when examining HPA axis response to stress in the laboratory, it is 
important to include a stable baseline measure of HPA axis functioning prior to stress 
exposure, as well as an adequate within-group control condition that includes no stress at 
all (Sinha, 2009). This final point is particularly important when attempting to draw 
conclusions about the extent to which a laboratory paradigm effectively induces an HPA 
axis response that is significantly different from what would have occurred in the absence 
of the stressor. Including a non-stressed control condition ensures sensitive measurement 
of basal HPA axis functioning and the ability to relate it to the experimental stress 
response. 
With the above considerations in mind, the following sections will provide 
descriptions of some of the specific laboratory stress paradigms that have been used to 
assess HPA axis reactivity to stress among chronic drug users, and provide a brief review 
of the extant literature on HPA axis reactivity to psychological stress among chronic 
substance users. Because it is beyond the scope of the current study to examine 
differences in HPA axis reactivity across drug classes, the following literature review will 
focus specifically on HPA axis dysregulation in crack/cocaine dependent individuals, as 





1.6 Overview of Existing Laboratory Stress Paradigms 
There are many laboratory paradigms that have been developed to study HPA axis 
reactivity to stress. The most well-established among them is the Trier Social Stress Task 
(TSST; Kirschbaum, Pirke, & Hellhammer, 1993) which is a standardized social stress 
test that involves the combination of a public speaking test and a challenging math task. 
The entire paradigm generally lasts between 10-15 minutes depending on the specific 
variation that is used, and this long exposure duration may partially underlie its ability to 
consistently produce a robust cortisol response (Sinha, 2009). Intense physical stressors 
have also been utilized to induce a physiological stress response, including a 90 second 
cold-presser task and hyperthermia tasks; however, the effects of these paradigms on 
HPA axis response in particular is generally low (Dickerson & Kemeny, 2004). Further, 
physiological stressors have rarely been utilized in the study of HPA axis response to 
stress among chronic cocaine users. As such, the following review will focus on two 
laboratory stress paradigms that have been specifically evaluated among chronic illicit 
substance users. 
Regarding the study of stress in the context of cocaine use, the most commonly 
used stressor is the personalized stress imagery procedure developed by Sinha and 
colleagues (unpublished manuscript) (see Section 2.4.2 for more details). Prior to 
experimental testing, participants complete a script development session in which are 
asked to describe a recent situation involving an interaction with another person, during 
which they were “mad, sad, or upset, and in which at that moment you felt as though you 
could not do much to change it”. A trained researcher then develops an auditory 




during the experimental testing session. The participant is instructed to “Imagine the 
situation as if it were happening right now. Allow your body to become completely 
involved in the situation, doing what you would do in the real situation”. Sinha and 
colleague’s stress imagery paradigm has a number of strengths, including the 
personalization of the stress script to fit individual perceptions of what is considered 
“stressful”, thus increasing the reliability of the paradigm for inducing an HPA axis 
response across individuals, as well as an element of “uncontrollability” given that 
participants are encouraged to choose a scenario in which “you felt as if you could not do 
much to change it”. Further, stress imagery scripts have proven to be a valuable tool in 
the field of cocaine addiction research as both subjective and physiological responses to 
this stress paradigm have been shown to predict substance use outcomes (Sinha et al., 
2006). However, there are some limitations in using the stress imagery paradigm. 
Specifically, the script development procedures are time consuming and can be resource 
intensive given that script development and training sessions must be conducted with all 
participants individually, separate scripts must be written for each individual condition, 
and Sinha and colleagues specifically recommend that only graduate or post-graduate 
level individuals conduct the script development sessions and generate the imagery 
scripts (Sinha, 2009; Sinha et al., unpublished manual). 
 Alternatively, the computerized Paced Auditory Serial Addition Task (PASAT-C; 
Lejuez, Kahler, & Brown, 2003) has been used in fewer studies of HPA axis functioning, 
but has shown considerable strengths as a stress induction strategy as well (see Section 
2.4.1 for more details). The PASAT-C is a challenging mathematical processing task that 




Moreover, while completing the task, participants are bombarded with constant forced 
failure and aversive auditory feedback. The PASAT-C clearly incorporates the crucial 
element of “uncontrollability” in the paradigm, given that the task is specifically designed 
to function at a level of difficulty that is impossible to complete successfully. It could 
also be argued to have a social evaluative component to the extent that participants 
complete the task (and invariably fail to complete it well) in front of the research assistant 
that administers the task. Additionally, behavioral responding to the PASAT (i.e., quitting 
the task; Daughters et al., 2005) and HPA axis response to the task (Daughters et al., 
2009) have both been shown to predict premature dropout from residential substance use 
treatment. Despite these strengths, the task lacks the personalization that is inherent in the 
stress imagery paradigm used by Sinha and colleagues, thus leaving it open to vast 
individual differences in the extent to which the task is perceived as being “stressful”, 
and potentially reducing the reliability and robustness with which it may activate the 
HPA axis stress response across individuals. 
   
1.7 HPA Axis and Addiction: Evidence from Human Research 
 A number of studies have used the acute laboratory stress paradigms described 
above to examine the relationship between stress, HPA axis functioning, and relapse 
among drug-dependent individuals. For example, a series of studies by Sinha and 
colleagues utilized the personalized stress imagery script paradigm to examine the 
relationship between stress, drug craving, HPA axis functioning, and treatment outcome 
in a sample of treatment-seeking cocaine dependent individuals. As a first step, Sinha, 




on cocaine craving and salivary cortisol concentrations. Ten cocaine dependent 
participants recently admitted to substance use treatment were recruited to participate. In 
each laboratory session, beginning at 3:00pm, participants were exposed to a 5-minute 
baseline period, two 5-minute imagery scripts (one neutral and one stressful) 
counterbalanced across participants, a 3-minute recovery period following each script, 
and a 10-minute break following the first script. Cortisol samples were collected 
following each baseline, imagery, and recovery period. Researchers found significant 
increases in cocaine craving, subjective anxiety, and heart rate, following the stressful 
imagery script compared to the neutral script. Researchers also reported a significant 
increase in salivary cortisol concentrations following the stressful imagery script; 
however, the reported increase was small (less than 0.1 µg/dl) compared to increases in 
cortisol of 0.2-0.3 µg/dl that have been reported in non-drug using participants following 
psychological laboratory stressors in other studies (e.g. Kirschbaum, 1993, 1995). 
Further, while subjective anxiety and heart rate decreased during the recovery period, 
cortisol concentrations continued to rise. However, both of these findings (i.e. the 
relatively small increase in cortisol following the stressor and the continued increase 
during the recovery period) may be explained by the 3-minute recovery period that was 
used to assess HPA functioning following the imagery scripts, which may not have 
allowed for a complete assessment of HPA response to the stressors. It has been found 
that cortisol secretion peaks 12 minutes after a stressor (Chatterton et al., 1997; 
Kirschbaum et al., 1993), and makes the transit from circulation to saliva in another 5 
minutes (Tunn et al., 1992). Therefore, a longer post-stressor assessment duration is 




limitation, this study provided the first documented evidence of a relationship between 
stress and drug craving in cocaine dependent individuals, and suggested that the method 
of stress that was utilized (i.e. stress imagery) is sensitive enough to bring about 
neurobiological changes in the form of increased salivary cortisol concentrations in 
response to stress.  
Building from this study, Sinha, Fuse, Aubin, & O’Malley (2000) extended their 
research by examining the effects of a stress imagery script and a drug imagery script on 
cocaine and alcohol craving, subjective ratings of anxiety, heart rate, and salivary cortisol 
concentrations within a sample of twenty treatment-seeking cocaine dependent 
participants. Laboratory procedures were very similar to the 1999 study, except 
participants were exposed to 3 imagery scripts in a single laboratory session (stress 
imagery, drug imagery, and neutral), and participants reported both cocaine and alcohol 
craving at each assessment throughout the session. Similar to the 1999 study, researchers 
reported increases in cocaine and alcohol cravings, subjective anxiety ratings, heart rate, 
and salivary cortisol concentrations following the stress and drug-cue imagery compared 
to neutral imagery. Although this study also faces the limitation of short recovery periods 
following stressors, findings suggested that psychological distress-induced and drug-cue-
induced cravings are both associated with similar patterns of HPA axis activation. 
A third study by Sinha et al (2003) utilized a longer recovery period as they again 
employed both stress- and drug-cue imagery scripts to examine HPA and sympatho-
adrenal-medullary responses to stress via blood samples for 75 minutes following 
exposure to the stressors. Fifty-four cocaine dependent individuals seeking treatment 




beginning in the second week of their treatment stay. Each laboratory session began at 
7:45am at which time participants were allowed a final smoke break. By 8:15am a nurse 
brought the participants into the testing room and inserted a catheter into the participant’s 
arm in order to obtain blood samples throughout the testing session. Participants were 
then given a 1-hour adaptation period during which they were instructed to relax. 
Beginning at 9:30am, participants were exposed to a 5-minute imagery script, during 
which their pulse was continuously measured and their blood pressure was measured four 
times. Cocaine craving, anxiety, pulse, blood pressure, and blood draws were made 
immediately following the imagery script, and every 15 minutes thereafter for a total of 
75 minutes. 
Similar to the 1999 and 2000 studies, Sinha and colleagues (2003) found 
significant increases in cocaine craving, anxiety, pulse, and blood pressure following the 
stress and drug imagery scripts compared to the neutral script. Plasma cortisol levels 
decreased following all three conditions; however, cortisol concentrations decreased 
significantly less following the stress and drug imagery scripts compared to the neutral 
scripts, suggesting a significant activation of the HPA axis in response to both the stress 
and drug-cue imagery conditions compared to the neutral condition. Although cortisol 
concentrations following both of the experimental conditions were significantly higher 
than concentrations following the neutral condition, the overall pattern of HPA reactivity 
to the stress and drug-cue imagery scripts (i.e., the decrease in cortisol following script 
exposure) was unexpected, and may provide additional support for the role of HPA axis 




A similar dysfunctional pattern of HPA axis reactivity to a laboratory stressor was 
shown by Harris and colleagues (2005) in a sample of cocaine and methamphetamine 
dependent individuals. Specifically, in the only study to our knowledge to examine HPA 
reactivity to two different psychological stress paradigms within the same sample of 
cocaine/stimulant users, Harris and colleagues (2005) recruited 24 cocaine- or 
methamphetamine-dependent participants with a median of 18 days since last drug use to 
examine the effects of repeated laboratory stressors on psychological, physiological, and 
hormonal measures. In laboratory sessions beginning at 1:30PM, researchers 
administered a stress-imagery task using the same protocol as Sinha et al. (1999), and the 
TSST two times each over the course of 4 sessions spaced apart by at least one day each. 
Researchers found no significant changes in cortisol concentrations following either 
TSST administration, and significant decreases in cortisol concentrations following both 
stress imagery scripts; however, no control condition (i.e. no stressor) was utilized to 
which these findings may be compared. Therefore, it is unclear what the pattern of 
cortisol concentrations would have looked like in the absence of stress. Additionally, the 
primary aim of this study was to assess the effect of repeated stress exposure on HPA 
axis response to the tasks; therefore, analyses were only conducted to compare HPA axis 
response to the first stress imagery administration versus the second stress imagery 
administration, and the first TSST administration versus the second TSST administration. 
No analyses were conducted to test for differences in HPA axis response to the two 
different tasks, leaving unanswered questions about whether the two tasks differed 




Lovallo and colleagues (2000) reported similar findings to Harris and colleauges 
(2005) using a stressor similar to the TSST in a sample of control, alcohol dependent, and 
alcohol + stimulant (cocaine and/or amphetamines) dependent participants who were 
abstinent for between 3-4 weeks. Participants were exposed to a 20 minute public 
speaking task and a neutral resting condition counterbalanced across two separate testing 
sessions, both running from 7:00am to 9:30am. Researchers found the expected increase 
in salivary cortisol concentrations following the stressor in control participants, but no 
significant change in cortisol concentrations among the alcohol dependent and alcohol + 
stimulant dependent participants.  
Finally, Daughters and colleagues also found evidence of a dysregulated pattern 
of HPA axis stress reactivity in a sample of illicit substance users (47.1% crack/cocaine 
dependent) in residential substance use treatment following exposure to computerized 
psychological stressors (Daughters, Richards, Gorka, & Sinha, 2009). Daughters and 
colleagues used the PASAT-C and one other computerized psychological stress task (the 
Mirror Tracing Persistence Task; MTPT-C) to examine the effects of emotional distress 
on HPA axis reactivity in illicit substance users in their second week of residential 
substance use treatment. Researchers reported a decrease in salivary cortisol levels 
following the stressors; however, similar to Harris and colleagues (2005), no neutral 
condition was employed in order to examine how HPA reactivity to stress compares to 
normal, non-distressed functioning, making these findings difficult to interpret. That said, 
these findings appear to provide yet another example of HPA axis dysregulation in illicit 





1.8 Summary and Significance 
Due to the prevalence and public health cost of drug addiction, it is imperative 
that researchers gain a deeper understanding of the mechanisms underlying substance use 
and relapse. One mechanism of interest is the role of dysregulated HPA axis functioning 
in response to psychological stress. Neurobiological theories, largely based on animal 
models of addiction and relapse, suggest that HPA axis dysfunction is a consequence of 
neuroadaptive changes resulting from chronic substance use, and that these changes in 
HPA functioning limit one’s ability to cope with additional psychological stress during an 
abstinence attempt and may increase the reinforcing effects of drug administration during 
periods of elevated distress, thereby increasing the risk of stress-induced relapse. In order 
to test these theories in human illicit drug users, laboratory stress paradigms have been 
developed to model stress in order to elucidate potential mechanisms underlying the 
relationship between stress and addiction, and translate these findings into novel 
treatment interventions for human drug users. A variety of stress paradigms have been 
used to examine HPA axis response to stress among illicit drug users, with findings 
largely corroborating animal models of addiction such that chronic drug use is associated 
with a blunted cortisol response to psychological stress (Daughters et al., 2009; Harris et 
al., 2005; Lovallo et al., 2000; Sinha et al., 1999; 2000; 2003), and a larger HPA axis 
response to stress is associated with poorer substance use outcomes (Daughters et al., 
2009; Sinha et al., 2006).  
Despite the advances that have been made in our knowledge of the physiological 
underpinnings of the relationship between stress and illicit substance use, unanswered 




compared HPA axis response to different types of psychological stressors among chronic 
drug users. Given the relationship between HPA axis dysfunction and substance use 
outcomes, an important aspect of modeling stress among drug users in the laboratory is to 
understand the extent to which HPA axis dysregulation is stressor-specific, or generalized 
across different types of stressful scenarios. Clearly, a direct comparison of HPA axis 
reactivity to different types of laboratory psychological stressors among a sample of 
chronic substance users who are characterized by stress dysregulation would be a critical 
advancement in the field of addiction neurobiology, with important clinical implications. 
In a first step to address this specific gap in the literature on HPA axis functioning 
among substance users, the current study seeks to examine the pattern of HPA axis 
response to two different previously validated psychological stressors, compared to a 
neutral no-stress condition, among cocaine-dependent individuals in residential substance 
use treatment. Examining HPA axis response to different types of psychological stress 
among chronic drug users represents a first step toward identifying the specific conditions 
under which individuals may be at the greatest risk of stress-induced relapse. 
Additionally, this line of research could be extended in the future to examine the links 
between the cognitive and affective responses associated with specific stressful 
circumstances, the neural substrates of these responses, and the activation of the HPA 
axis. Both of these long-term research efforts have the potential to substantially inform 
the development of novel behavioral and pharmacological treatments designed to target 






1.9 Current Study 
The current study aims to directly compare HPA axis reactivity among cocaine 
dependent individuals to three different conditions: a personalized stress imagery script, a 
personalized neutral “no stress” imagery script, and a non-personalized computerized 
stress task. We will use three different approaches for analyzing the cortisol data 
collected during each experimental condition in order to fully characterize the specific 
pattern, magnitude, duration, and intensity of the cortisol response across the three 
conditions. Moreover, including multiple analytic approaches to examining the cortisol 
data will provide information about the reliability and the robustness of the differential 
effects of the three experimental conditions on HPA reactivity. In doing so, we 
hypothesize that the personalized stress imagery script will induce a greater salivary 
cortisol response than the personalized neutral imagery script, the computerized 
psychological stress task (i.e., the PASAT-C) will induce a greater salivary cortisol 
response than the personalized neutral imagery script, and the personalized stress imagery 
script will induce a greater salivary cortisol response than the PASAT-C. These 
relationships between the three conditions will be manifested in the following ways: 
Hypothesis 1: Linear mixed effects (LME) analyses predicting salivary cortisol 
concentrations across time following exposure to the experimental conditions will 
reveal:  
Hypothesis 1a: Significantly greater cortisol concentrations across time 
points during the stress imagery condition as compared to neutral imagery. 
Hypothesis 1b: Significantly greater cortisol concentrations across time 




Hypothesis 1c: Significantly greater cortisol concentrations across time 
points during the stress imagery condition as compared to the PASAT. 
Hypothesis 2: LME analyses predicting peak cortisol response to the three 
conditions will reveal: 
Hypothesis 2a: Significantly greater peak cortisol response to the stress 
imagery condition as compared to neutral imagery. 
Hypothesis 2b: Significantly greater peak cortisol response to the PASAT 
condition as compared to neutral imagery. 
Hypothesis 2c: Significantly greater peak cortisol response to the stress 
imagery condition as compared to the PASAT. 
Hypothesis 3: LME analyses predicting area under the curve (AUC) values across 
the three conditions will reveal: 
Hypothesis 3a: Significantly greater AUC values in response to the stress 
imagery condition as compared to neutral imagery. 
Hypothesis 3b: Significantly greater AUC values in response to the 
PASAT condition as compared to neutral imagery. 
Hypothesis 3c: Significantly greater AUC values in response to the stress 
imagery condition as compared to the PASAT. 
 
1.10 Methodological Considerations in HPA Axis Research 
 When conducting and evaluating HPA axis research, there are a number of 
methodological and individual difference factors that may systematically influence 




of diurnal variation on salivary cortisol sampling. Specifically, cortisol secretion tends to 
follow a distinct circadian rhythm with cortisol levels peaking in the morning within 20-
45 minutes of awakening (Stone et al., 2001). The subsequent decline is sharpest during 
the morning hours, and becomes less steep over the course of the day (Lovallo, 2006). 
This steep morning decline in cortisol concentrations may explain the extremely 
dysregulated stress response that was reported by Sinha and colleagues (2003; 2006). 
Due to this wide range of diurnal variation, it is crucial that researchers carefully control 
and document the time of sampling across participants, and choose a time in the diurnal 
cortisol curve in which steep changes are not the norm, in order to avoid the confounding 
influence of normal diurnal variation on cortisol reactivity to stress. As such, the current 
study collected all cortisol samples in the evening when cortisol concentrations have 
reached their circadian nadir. 
 Within individuals, factors such as age and gender may exert systematic 
variability on cortisol findings. Older individuals (>70 years old) have shown higher 
basal levels of salivary cortisol and reduced cortisol reactivity to stress compared to 
younger individuals (Nicolson et al., 1997). Gender differences have also been found, 
with researchers reporting a smaller salivary cortisol response to psychological stress in 
both healthy women (Kirschbaum, et al., 1999) and cocaine dependent women (Fox, 
Garcia et al., 2006) than in men. Further, menstrual cycle phase and use of oral 
contraceptives have also been found to systematically influence salivary cortisol response 
to psychological stress, with women in the luteal phase showing greater cortisol reactivity 
than women in the follicular phase, and women currently taking oral contraceptives 




who are not (Kirschbaum, et al., 1999). Therefore, the current study controlled for these 
factors by limiting the age range to 18-55, and excluding females from participating. 
 Additional factors such as psychopathology, medications, and nicotine use may 
also influence findings. A number of psychological disorders have been associated with 
alterations in HPA axis functioning, including hypocortisolism in adults with PTSD (see 
Yehuda, 2002 for review) and hypercortisolism in depressed individuals (e.g. Galard et 
al., 1991; see Carroll & Mendells, 1976 for an early review). Further, medications 
prescribed to treat psychopathology may alter HPA axis functioning, with individuals 
taking benzodiazepines showing an attenuated HPA axis response to psychological stress 
(Fries, Hellhammer, & Hellhammer, 2006). Finally, increased basal salivary cortisol 
concentrations and reduced cortisol reactivity have been documented in habitual smokers 
(al’ Absi, Wittmers, Erickson, Hatsukami, & Crouse, 2003; Kirschbaum, Strasburger, & 
Langkrar, 1993; Steptoe & Ussher, 2006; Tersman, Collings, & Eneroth, 1991). As such, 
the current study addressed these issues by excluding individuals with Axis I 
psychopathology, as well as individuals who were prescribed psychotropic medications. 
Given the high frequency of nicotine use in the residential treatment center, it was not 
feasible to exclude habitual cigarette smokers. Therefore, steps were taken to assess 
smoking status through both self-report and biological methods to test for a significant 
effect of nicotine use on HPA axis functioning. 
 Finally, there are many mathematical and statistical approaches that can be used 
to examine time-series cortisol data, including assessing the general pattern of cortisol 
secretion across time points using the general linear model, calculating the peak cortisol 




change from baseline, and calculating area under the curve (AUC) for each condition in 
order to measure the total cortisol output over time (see section 2.6 for more details). 
Because each of these approaches captures slightly different information pertaining to the 
HPA axis response to stress, it may be useful to use more than one approach to examine 
cortisol data in order to gain a better understanding of the reliability and robustness of 
any significant effects on cortisol functioning. As such, the current study will test for 

































Chapter 2: Research Design and Method 
2.1 Overall Design  
 A within subjects 3x5 repeated measures design was used with condition (3; 
PASAT, Stress Imagery Script, and Neutral Imagery Script) and time-point (5; post-stress 
exposure cortisol assessment time points) as the repeated measures factors. The PASAT, 
stress imagery, and neutral imagery conditions were presented on separate testing days 
with only one stimulus presentation per day. Every attempt was made to conduct the 
three laboratory sessions on consecutive days for each participant, unless there was a 
scheduling conflict with the research staff or the participant (mean number of days to 
complete all three laboratory sessions: 4.0; SD= 1.7). The order of PASAT, stress 
imagery, and neutral imagery conditions was assigned randomly. Testing sessions 
commenced an average of 16.63 days (SD=7.15) after admission to the residential 
treatment center to allow for normalization of neurobiological changes associated with 
acute cocaine abstinence. Participants remained blind to the order of the testing condition 
until their arrival in the testing room each day. 
 
2.2 Recruitment 
Participants (n=22) recruited for this within subjects study were inner-city 
substance users living in a residential substance use treatment facility located in 
Washington DC. Treatment at this center involves a mix of strategies adopted from 
Alcoholics and Narcotics Anonymous as well as group sessions focused on relapse 
prevention and functional analysis. When needed, detoxification from an outside source 




and aside from scheduled activities (e.g., group retreats, physician visits), residents are 
not permitted to leave the center grounds during treatment. Complete abstinence from 
drugs and alcohol is required upon entry into the center and throughout the duration of 
the program, with the exception of nicotine. Regular drug testing is provided and any 
drug or alcohol use results in immediate dismissal from the center; therefore, acute drug 
effects likely did not influence the current findings. 
 Within the first week of admission to the treatment center, all individuals entering 
the center had a screening assessment session in which they were given the SCID-IV-NP 
(First et al., 2002) and a standard drug use history interview (DUH; e.g., Babor & Del 
Boca, 1992; Grant, Contoreggi, & London, 2000; Daughters, Lejuez, Bornovalova, et al., 
2005). Individuals who conducted the intake assessments were trained interviewers 
predominantly independent of the current study. Recruitment for the study was based on 
the initial assessment. Inclusion criteria consisted of the following: 1) age 18-55 years of 
age; 2) male; and 3) DSM-IV diagnosis of current cocaine dependence as measured by 
the SCID-IV-NP (First et al., 2002). Clients were excluded from the study if 1) they met 
DSM-IV criteria for opiate abuse or dependence (as measured by the SCID-IV-NP, First 
et al., 2002); 2) met DSM-IV diagnostic criteria for any current Axis I disorder or 
psychotic symptoms (as measured by the SCID-IV-NP, First et al., 2002); 3) reported 
current use of psychotropics or corticosteroids; and 4) reported any current major medical 
conditions, including but not limited to neurological illness, diabetes, HIV/AIDS, 
autoimmune disorders, and cardiovascular disease.  
  Residents at the treatment center who met initial eligibility requirements based on 




following Friday afternoon (no center implemented treatment groups are scheduled for 
these times). The research assistant asked the resident if they would like to participate in 
a study that focuses on the relationship between mood and substance use. They were told 
that they would complete a screening assessment that day that would last up to 1.5 hours 
in order to confirm their eligibility. Study staff informed participants that upon 
confirmation of study eligibility and completion of the baseline session, they would be 
scheduled for a one hour training session to learn the study procedures, and three 1.5-
hour testing sessions, all to be completed in the following week. Participants were 
informed that not all individuals who participate in the screening would be chosen to 
complete the remainder of the study. Participants were also informed that payment in the 
form of grocery store gift cards would be provided for all research assessments ($15 for 
each study session, plus a $20 bonus for completing all research assessments). 
Individuals who agreed to participate in the study provided informed consent and were 
assigned subject numbers that were listed on all data forms. Given issues of reading 
comprehension, efforts were made to ensure that participants understood all facets of the 
consent form and the study itself. All testing sessions were held in private rooms at the 
residential treatment facility during designated “free time” periods at the center.  
After obtaining informed consent, the baseline session commenced, beginning 
with a thorough Health Screening Questionnaire (HSQ) and a Medication Questionnaire. 
Once participants were determined to meet all eligibility criteria on the basis of their self-
reported health status and list of current medications, the session continued with a packet 
of questionnaires and an imagery script development interview (outlined below). If 




meet eligibility criteria based on the results of their HSQ and Medication Questionnaire 
(which happened three times during recruitment) they were able to return to unsupervised 
free time activities to prevent any knowledge by treatment center staff as to whether or 
not they had chosen to participate, thereby limiting any appearance of coercion to 
participate. Individuals who were dismissed from the study due to ineligibility were 
compensated $10 in grocery store gift cards before returning to center activities.  
 
2.3 Testing Procedures 
2.3.1 Session 1 (Consent, Imagery Script Development, and Questionnaires)  
Once consent was provided, participants began the screening assessment (Session 
1) in a private room. Session 1 began with the HSQ and Medication Questionnaire (as 
outlined above) in order to confirm their eligibility, as well as a packet of baseline self-
report measures which included the demographics questionnaire. A member of the 
research staff was available at all times to provide instruction and answer questions. As a 
part of a larger study, participants were also administered the PASAT and given the 
option to quit the task in the final round in order to assess distress tolerance. Distress 
tolerance data collected at baseline was not analyzed for the current study.  
Following completion of the baseline measures, eligible participants were asked 
to recount a recent stressful event which was tape recorded and used for the stress 
imagery script development (See section 2.4.2). They also reviewed a list of standard 
neutral scripts and selected one to be used for the neutral script development (See section 
2.4.3). Participants were then scheduled to participate in the training session and testing 




various procedures to follow on each day of each testing session in which cortisol was 
collected. Namely, they were given the time at which they were requested to eat their 
final meal and smoke their last cigarette before attending the testing session. Further, they 
were reminded not to consume any caffeine and asked to avoid physical exercise for 4 
hours prior to testing. In addition to making these requests, we also collected their self-
reported adherence to these requests, as well as exhaled carbon monoxide levels, at the 
beginning of each testing session in order to assess the effects of any deviations from the 
study procedures statistically. The order of the testing sessions was randomized across 
participants, and the participants were blinded to experimental condition until the time 
they arrived in the testing room each night. 
 
2.3.2 Session 2 (Imagery and Relaxation Training Session) 
To further reduce the variability in imagery ability, participants completed a 
relaxation and imagery response training session, as recommended by Sinha (unpublished 
manual). Imagery training has been found to reduce the effects of variability in baseline 
imagery ability across participants (Miller et al., 1987). The relaxation training consisted 
of a 20-minute progressive muscle relaxation procedure that allowed the participants to 
achieve a relaxed state and focus on the imagery training that followed.  
The imagery training involved participants visualizing some commonplace scenes 
as they were presented to them. The scenes were neutral and non-emotional in content, 
such as reading a popular magazine. Following the imagery, the participants were asked 
questions about the visualization and given pointers regarding the process of imagining 




arousing in nature, such as doing sit-ups in gym class. Following these scenes, 
participants were asked whether they noticed any changes in their physiological response, 
such as change in heart rate or change in breathing. Once again, pointers with regard to 
imagining the situation "as if it were happening right now” were presented. The 
participant’s active participation in the imagery was emphasized. The relaxation and 
imagery training procedure lasted approximately one hour and ensured that all 
participants were trained on the method of generating an image and maintaining it for the 
assigned time period. After the image period for each scene, participants were 
administered the Imagery Vividness Scale (IVS) on which they made a rating on a 10-
point visual analog scale (with 1= not at all clear, and 10=perfectly clear – “as if it were 
happening now”) for how "clearly and vividly" they were able to imagine the situation.  
 
2.3.3 Sessions 3, 4, & 5 (Cortisol Testing Sessions) 
Testing sessions were run after dinner at the residential treatment center (See 
Figure 1 for a diagram of testing session procedures). Participants were asked to smoke 
their last cigarette 60 minutes before each testing session commenced in order to control 
for the effects of acute nicotine administration. Upon arrival in the testing room, 
participants completed a protocol compliance interview and provided exhaled carbon 
monoxide levels. Next, they were walked through a 5-minute muscle relaxation exercise, 
followed by a 5-minute rest period during which they were asked to relax and focus on 
their breathing, for a total of 10 minutes of relaxation. The first saliva sample was taken 
immediately following the deep breathing exercise and the second was taken following 




“pre-stress” cortisol concentration for each testing session. Participants then completed 
one of the three experimental conditions (PASAT, Stress Imagery Script, or Neutral 
Imagery Script), immediately followed by saliva sample collection. Participants were 
asked to fill out the PANAS before and after each task in order to measure subjective 
levels of distress. Exposure to the experimental condition was then followed by 40 
minutes of rest, during which cortisol samples were collected every ten minutes. During 
this time, participants sat comfortably in a cushioned chair and read magazines. After 40 
minutes passed, the participants again filled out the PANAS to ensure that all participants 
reported levels of distress at the end of the session that were comparable to baseline 
levels. Participants also filled out a Nicotine Withdrawal Scale at the beginning and end 
of each session in order to assess for the acute effects of nicotine withdrawal on cortisol 
reactivity in the final analyses. Once all measures were complete, the participants were 
compensated and thanked for their time, and reminded of the date and time of their next 
testing session visit. The order of the tasks was randomized across all participants. 
Participants were coded based on the order in which they received the tasks in order to 
analyze the final data for any potential order effects. 
 
2.4 Experimental Conditions 
2.4.1 PASAT 
The computerized psychological stress task was a modified version of the 
computerized Paced Auditory Serial Addition Task (PASAT-C; Lejuez, Kahler, & 
Brown, 2003). The PASAT-C (see Figure 2) has been shown to increase subjective stress 




cessation attempt (Brown et al., 2002), length of previous abstinence attempt among 
illicit drug users (Daughters, Lejuez, Kahler, et al., 2005), and dropout from substance 
abuse treatment (Daughters, Lejuez, Bornovalova, et al., 2005). For this task, numbers 
are sequentially flashed on a computer screen, and participants are asked to add the 
currently presented number to the previously presented number before the subsequent 
number appears on the screen. As the task is designed to limit the role of mathematical 
skill in persistence, the presented numbers only range from 0 to 20, with no sum greater 
than 20. Participants are told that their score increases by one point with each correct 
answer and that incorrect answers or omissions will not affect their total score. There are 
three levels of difficulty, lasting two minutes each. The first level begins with a 5-second 
latency in between number presentations and titrates this latency based on performance 
(correct answers reduce the latency by 0.5 seconds whereas incorrect answers or 
nonresponses increase the latency by 0.5 seconds). Titration in this manner allows for 
determination of the average latency between number presentations for each participant, 
which is used to limit confounds associated with differential math skill and reaction time. 
The second level is more difficult, as the latency between number presentations is set to 
75% of the average latency that was determined in the first level. The final level utilizes 
an extremely difficult challenge latency, which is set to 50% of the average latency from 
level one. Further, the participant is inundated with constant aversive auditory feedback 
in the form of explosions for each incorrect answer or missed response. To make the task 
even more distressing, participants are told that their performance on the task influences 
how much money they will get at the end of the session. In previous studies, and during 




task at any time during the third round, and distress tolerance was indexed as latency in 
seconds to task termination. However, during the cortisol testing sessions in the current 
study, the PASAT was used only as a means to induce cortisol reactivity to stress; 
therefore, participants were not given the option to quit. All participants completed the 
PASAT for the full task duration. 
 
2.4.2 Stress Imagery Scripts 
Prior to participating in the actual testing sessions, a personalized stress imagery 
script was developed for each participant, using the same script development protocol as 
Sinha and colleagues (unpublished manual). That is, participants were asked to recount a 
recent stressful situation, not involving drug use. Participants were encouraged to think of 
situations that were interpersonal in nature, that made them “sad, mad, or upset” and in 
which, at that moment, they felt as if they “could not do much to change it” (Sinha et al., 
unpublished manual). After describing the situation to the researcher, participants were 
asked to rate their level of distress during the situation on a 10-point Likert type scale, 
and only situations that were rated as 8 or higher were used. Examples of situations that 
were used for script development include a break-up with a significant other, an argument 
with a friend or family member, or unemployment related stress such as being fired or 
laid off from a job. Participants were asked to describe all of the details that they could 
remember about the situation, including thoughts, behaviors, and physiological reactions 
to the stressor (e.g., pounding heart, muscle tension, shortness of breath). A 6-minute 
script was then developed based on the participant’s description of the situation and was 




administration, participants were provided with headphones and given the following 
instructions, “Close your eyes and imagine the situation being described, as if it were 
happening right now. Let your body and mind get completely involved in the situation, 
doing what you would do in the real situation. Continue imagining until I tell you to 
stop.” The length of each script was approximately 6 minutes followed by 30 seconds of 
continued imagining, for a total imagery period of 6.5 minutes. All participants 
completed the IVS immediately following script administration to assess their ability to 
participate fully in the imagery and become completely immersed in the scene. 
 
2.4.3 Neutral Imagery Scripts 
 A neutral imagery script was also developed for each participant prior to 
participation in the testing sessions. Each participant was provided a list of common 
relaxing situations, such as going for a walk alone, quietly reading or listening to music, 
or taking a hot shower or bath. Participants chose one of the relaxing scenarios and 
recounted a recent time when they experienced a similar source of relaxation in their own 
life. Again, participants were asked to recount as many details as possible about the 
situation, including their thoughts, feelings, and physiological responses. Neutral imagery 















Basic information on age, gender, race, 
education level, marital status, and total 
household income 
SCID-IV-NP 
Diagnostic information (All Axis I 
Psychopathology) 
DUH Assessment of drug use history  
Medication 
Questionnaire 
Frequency, dosage, and type of various 
medications, including psychotropic, non-




Assessment of additional variables that may 
influence HPA axis functioning including 
sleep quality, BMI, caffeine consumption, 
history of immune dysfunction. 
Affective and Imagery 
Vividness Measures 
PANAS 
Assesses state level positive and negative 
affect 
IVS 
Single item Likert-type scale used to assess 
how vividly participants imagined the scripts 
Smoking 
 
NWQ Assesses severity of withdrawal symptoms 
Biological Measures 
Salivary Cortisol Assessment of HPA functioning 
Carbon Monoxide 
Assessment of expired air carbon 
monoxide levels 
 
2.5.1 Clinical Interview and Questionnaires 
1. Demographic Questionnaire. Subjects provided basic demographic information 
including age, gender, education level, occupation, home occupants, and socioeconomic 
status.  
2. Structured Clinical Interview for DSM-IV (SCID-NP, non-patient version, 
First, Spitzer, Gibbon & Williams, 2002). Diagnostic inclusions/exclusions, including 
Axis I diagnoses and substance use disorders were determined using the SCID-NP, a 
measure with demonstrated reliability (First, Spitzer, Gibbon & Williams, 2002). The 
SCID-NP (non-patient) version was used because subjects in the study are not identified 




3. Drug Use History. As a measure of substance use frequency and severity, 
polydrug use was assessed with a standard Drug Use History Questionnaire (e.g., Babor 
& Del Boca, 1992; Grant, Contoreggi, & London, 2000; Daughters, Lejuez, Bornovalova, 
et al., 2005). Specifically, participants were asked if they have ever used a particular 
substance in their lifetime, how often they used it in the past year prior to treatment, and 
how often they used the substance during the period of their life when they were using it 
most frequently. The substance categories included: (a) marijuana, (b) alcohol, (c) 
cocaine (not crack), (d) crack, (e) ecstasy, (f) Methamphetamines, (g) sedatives, (h) 
heroin, (i) illegal prescriptions, (j) and PCP. 
  4. Medication Questionnaire. Self-report assessment of which medications 
participants were taking currently (if any), how long they had been taking these 
medications, as well as dosage and frequency. Medication was coded as a dichotomous 
variable, and divided into status on the following: selective serotonin reuptake inhibitors, 
SSRIs; anxiolytics; atypical antipsychotics; other psychotropic medications, and other 
medications including over-the-counter antihistamines, sleep aids). Patients were 
excluded if they endorsed current use of any psychotropic medications or corticosteroids. 
5. Health Screening Questionnaire.  This questionnaire was used to assess 
additional variables that can influence HPA axis functioning including sleep quality, 
BMI, caffeine consumption, and history of immune dysfunction. Further, a modified 
version was readministered at the beginning of each testing session to check for 
compliance with the study protocol. 
6. Positive and Negative Affect Scale (PANAS; Watson, Clark Tellegen, 1988). 




reflects the extent to which a person feels enthusiastic, alert, and active. NA reflects a 
person’s subjective distress and encompasses a number of negative mood states including 
anger, contempt, disgust, and guilt. NA is related to self-reported stress and poor coping 
(Clark & Watson, 1988) and frequency of unpleasant events (Stone, 1981). The PANAS 
was administered immediately before and after each task to assess the subjective level of 
distress experienced in response to the tasks. 
7. Imagery Vividness Scale (IVS; Sinha et al., unpublished manual). The IVS is a 
single-item Likert scale that was designed to measure the extent to which participants 
were able to imagine the personalized imagery scripts vividly. After completing each 
imagery script, participants were asked to rate on a scale of 1 to 10 how clearly they were 
able to imagine the scene. The IVS was used after each imagery exercise during the 
training session, and after each personalized imagery script on the testing nights of the 
study.  
8. Nicotine withdrawal symptoms were assessed at the beginning and end of each 
cortisol testing session using a reliable and sensitive, 10-item scale (Hughes & 
Hatsukami, 1986). This measure will be used to control for nicotine withdrawal 
symptoms, including craving, as they have been associated with decreases in cortisol 
concentration and are likely to occur over the course of the long testing session. 
 
2.5.2 Biological Measures 
1. Salivary Cortisol. Cortisol, a glucocorticoid, is the primary biological marker 
that is used to study the stress response in humans. In recent decades, salivary cortisol has 




response (Mandel, 1993). Studies have consistently shown a significant relationship 
between salivary cortisol levels and cortisol concentration in the blood stream (Burke et 
al., 1985; Chatterton et al., 1997; Fox et al., 2006; Heiser et al., 2000; Tunn et al., 1992), 
providing support for the use of salivary cortisol as a measure of HPA axis functioning. 
Cortisol secretion peaks approximately 12 minutes after a stressor (Chatterton et al., 
1997; Kirschbaum et al., 1993), and makes the transit from circulation to saliva in 
another 5 minutes (Tunn et al., 1992). The reliability of salivary cortisol has been 
examined specifically in cocaine users, and has been found to correlate significantly with 
plasma cortisol levels at multiple time points throughout the day (Fox et al., 2006), thus 
providing further evidence of the utility of salivary cortisol as a reliable measure of HPA 
functioning in cocaine users. 
In the current study, samples were collected using supplies purchased from 
Salimetrics®. To collect the samples, participants were asked to place a small inert 
polymer cylindrical swab underneath their tongue for 2 minutes. The participants then 
removed the saturated swab from their mouths and placed it into a labeled resealable 
polypropylene tube. Immediately after each testing session, all salivary cortisol samples 
were stored in a deep freezer at CAPER until they were shipped for analysis. All cortisol 
samples were sent to the Biochemistry Laboratory at the University of Trier, where they 
were assayed in duplicate using a time-resolved immunoassay with fluorescence 
detection (for technical details see Dressendörfer et al., 1992). The mean and coefficient 
of variance (CV) were computed for each duplicate assay. Samples that showed a CV 




reanalyzed. The results of each assay were recorded in an excel spreadsheet which was 
emailed directly to the primary investigator from the University of Trier. 
2. Expired air carbon monoxide. Carbon monoxide analysis of breath samples 
was assessed with a Vitalograph Breathco carbon monoxide monitor (Jarvis et al., 1987). 
Expelled carbon monoxide concentrations were used to assess acute cigarette exposure at 
the beginning of each testing session, and was examined as a potential covariate. 
 
2.6 Statistical Analyses 
 To address the primary study hypotheses that cocaine dependent individuals will 
exhibit (1) a greater salivary cortisol response to the personalized stress imagery script 
relative to the neutral imagery script; (2) a greater salivary cortisol response to the 
PASAT as compared to the neutral imagery script; and (3) a greater salivary cortisol 
response to the personalized stress imagery script relative to the non-personalized 
PASAT, a number of steps were undertaken as outlined below. First, we conducted a 
manipulation check to examine whether exposure to the two experimental stressors 
effectively induced increased levels of subjective distress, while exposure to the neutral 
condition had no significant effect on subjective distress. To do this, we conducted 
separate repeated measures ANOVAs for each experimental condition to test for 
differences between pre- and post-task ratings of negative affect on the PANAS. In order 
to test whether participants were equally able to actively participate in the imagery 
procedures across both the stress and neutral imagery conditions, we conducted a 





The next step included an examination of potential covariates. This included a 
comparison of baseline (i.e., pre-stress) salivary cortisol concentrations across the three 
nights of testing to test for potential differences in cortisol functioning that were not 
related to experimental condition exposure. Additionally, we examined the effect of 
testing order on cortisol concentrations. We also tested for significant differences in 
exhaled CO concentrations, baseline (i.e., “pre-stress”) levels of self-reported emotional 
distress as measured by the negative affect subscale of the PANAS at the beginning of 
each session, and differences in nicotine withdrawal symptoms across sessions as 
measured by the NWQ. Any potential covariates that were found to differ significantly 
across the three nights of testing were included as covariates.  
Next, linear mixed effects models (LME; Laird & Ware, 1982; Singer & Willett, 
2003) were implemented using the PASW software package to test the study hypotheses. 
LME is particularly well suited for designs that call for repeated measurements within the 
same individual that can lead to multicollinearity between the measurements. 
Additionally, such models are useful when there is missing data, as they prevent 
exclusion of subjects with missing data points (Littell et al., 1996). Because the raw 
cortisol values, peak cortisol values, and AUC variables all yielded substantially 
positively skewed distributions, log10 transformations were used to normalize the 
distributions of the cortisol outcome variables (Tabachnick & Fidell, 2001). In all LME 
analyses that included a linear effect of time, we centered the time variable for 





2.6.1 Salivary Cortisol Concentrations across Time 
The first LME was conducted with the log10 transformed cortisol concentrations 
as the dependent variable, and included within subjects factors of Condition (3 levels; 
PASAT, Stress Imagery, Neutral Imagery) and Time (centered) (5 levels; immediately 
post-task, +10min, +20min, +30min, +40min) as the fixed effects, and Subjects as the 
random effect. Between subjects factors of relevant covariates, including testing order 
and baseline (pre-stress) cortisol concentrations, as well as other relevant covariates, were 
also included as fixed effects. Post-hoc contrasts were used to assess the subhypotheses 
that the stress imagery condition would elicit significantly greater cortisol concentrations 
than neutral imagery, the PASAT would elicit significantly greater cortisol 
concentrations than neutral imagery, and the stress imagery would elicit significantly 
greater cortisol concentrations than the PASAT. 
 
2.6.2 Peak Cortisol Response 
Next, we calculated peak cortisol responses across each night of testing for all 
participants. Specifically, we calculated the difference between baseline cortisol 
concentrations (i.e., the mean of the two pre-stress cortisol assessments) and the greatest 
cortisol concentration recorded during the 40 minutes of rest following each task. This 
method was utilized in order to account for individual differences in the time it takes to 
reach peak response to the stressor. To test the effect of experimental condition on log10 
transformed peak cortisol values, a linear mixed effects model was implemented with the 
within subjects factor of Condition (3 levels; PASAT, Stress Imagery, Neutral Imagery) 




random effect. Post-hoc contrasts were used to assess the specific subhypotheses that the 
stress imagery condition would elicit a significantly greater peak cortisol response than 
neutral imagery, the PASAT would elicit a significantly greater peak cortisol response 
than neutral imagery, and the stress imagery would elicit significantly greater peak 
cortisol response than the PASAT. 
 
2.6.3 Area Under the Curve 
To test the final subhypotheses, area under the curve (AUC) values were 
calculated for each experimental testing session across all participants. Computation of 
AUC is commonly used in endocrinological research involving repeated measurements 
over time because it increases the power of testing compared to other methods (e.g., 
repeated measures ANOVA using individual cortisol samples) without sacrificing 
information contained in multiple measurements (Pruessner et al., 2003). Pruessner and 
colleagues outlined two different approaches to computing AUC. The first approach, 
termed “area under the curve with respect to ground” (AUCG) is calculated based on the 
distance of each measurement (i.e., each cortisol concentration) from zero, and most 
closely represents the overall intensity of hormonal output over time. The second 
approach, termed “area under the curve with respect to increase” (AUCI) is calculated 
based on the distance of each measurement from baseline (i.e., pre-stress), and is most 
closely related to the overall magnitude of change over time, with positive values 
representing an increase and negative values representing a decrease over time. Given 
that each approach emphasizes two different characteristics of the data, two separate 




values as the dependent variable, and once with log10 transformed AUCI values as the 
dependent variable. In both models, the within subjects factor of Condition (3 levels; 
PASAT, Stress Imagery, Neutral Imagery) and between subject covariate factors were 
included as the fixed effects, and Subjects as the random effect. Post-hoc contrasts were 
used to assess the specific subhypotheses that the stress imagery condition would elicit 
significantly greater AUC values than neutral imagery, the PASAT would elicit 
significantly greater AUC values than neutral imagery, and the stress imagery would 




Chapter 3: Results 
3.1 Participants 
A total of 22 participants were approached for recruitment in the study. Of these, 
2 participants declined participation. Thus, 20 participants provided informed consent and 
were enrolled in the study. Of these, 4 were excluded either for (a) reporting a major 
medical condition that was not disclosed during the initial SCID-IV-NP interview (n = 3) 
or for (b) providing undetectable salivary cortisol data (n = 1). Thus, the data analysis for 
the current study is based on a sample of 16 participants. Participants ranged in age from 
29 to 54 (M = 46.44, SD = 7.05). With regard to racial/ethnic background, all 16 
participants (100% of the sample) were African American. In terms of highest education 
level, 25.0% (n = 4) reported less than a high school education, 43.75% (n = 7) reported 
completing high school or obtaining a GED, and 31.25% (n = 5) reported some college or 
technical school. Nearly half of the sample reported current unemployment (43.75%, n = 
7), and the majority of the sample reported an average household income of less than 
$30,000 a year (68.75%, n = 11). Thirteen of the 16 participants (81% of the sample) 
endorsed smoking cigarettes on a daily basis. Demographic information is shown in 
Table 1. 
 
3.2 Manipulation Checks 
Separate repeated measures ANOVAs revealed a significant increase in distress 
(as measured by the negative affect scale of the PANAS) following experimental 
administration of the stress imagery script [F(1, 15) = 12.49; p = 0.003], but a non-




15) = 3.86; p = 0.068]. Notably, although the increase in distress following PASAT 
administration was not statistically significant, it did approach significance, with an effect 
size that was small, but generally considered significant in the social sciences literature 
(partial η2 = 0.205) (Cohen, 1988; 1992). Additionally, we examined ratings on 
individual items of the PANAS negative affect scale and found significant increases in 
response to PASAT administration on two items including “Distress” [F(1, 15) = 6.361, p 
= .02] and “Upset” [F(1, 15) = 5.993, p = .03], but no significant increase in ratings on 
the other eight items, including “Irritable”, “Guilty”, “Scared”, “Hostile”, “Ashamed”, 
“Nervous”, “Jittery”, and “Afraid”. There was no significant change in negative affect in 
response to the neutral imagery script [p = 1.000]. See Table 2 for pre- and post-task 
negative affect data across the three testing conditions.  
A repeated measures ANOVA was also conducted to test for significant 
differences in imagery vividness scale (IVS) ratings across the two imagery conditions. 
Analyses revealed a significant effect of imagery condition on participant ratings of 
imagery vividness [F(1, 15) = 9.62; p = 0.007]. Specifically, participants reported 
significantly higher imagery vividness for the stress imagery condition (M = 9.56; SD = 
0.89) as compared to the neutral imagery condition (M = 8.94; SD = 1.12). As such, 
imagery vividness ratings during the two imagery conditions were included as covariates 
in all subsequent analyses to control for the effect of imagery vividness on salivary 





3.3 Examination of potential covariates 
 First, we implemented a linear mixed effects model to test for significant 
differences in log10 transformed cortisol concentrations at baseline (i.e., the mean of 
time-points 1 and 2; “pre-stress”) across experimental conditions. To do this, we 
implemented a separate linear mixed effects model with the within subjects factor of 
Condition (3; PASAT, Stress Imagery, Neutral Imagery) included as a fixed factor, and 
subjects included as the random factor. The results revealed no significant difference in 
baseline cortisol concentrations across conditions [p = 0.17]. We then tested for 
significant differences across conditions at time-point 1 and 2 individually. We 
implemented separate LMEs including the within subjects factor of Condition (3; 
PASAT, Stress Imagery, Neutral Imagery) a fixed factor, and subjects as the random 
factor. The results revealed a significant difference in cortisol concentrations at time-
point 2 [F(1, 15.825) = 5.610; p = 0.03], reflecting significantly higher cortisol 
concentrations at time-point 2 in the Neutral Imagery condition (M = 0.498; SD = 0.449) 
as compared to the Stress Imagery condition (M = 0.272; SD = 0.298) and the PASAT 
condition (M = 0.216; SD = 0.351). As such, given the difference between pre-stress 
cortisol values at time-point 2, we took the conservative approach and chose to control 
for baseline (mean of time-points 1 & 2) in all subsequent analyses to insure that any 
differences that were found across conditions were not simply due to pre-stress 
differences in cortisol concentrations. 
 We used similar LMEs to test for significant differences in other variables that 
may have influenced HPA axis functioning across the three nights of testing, including 




affect as measured by the negative affect scale of the PANAS, and nicotine withdrawal 
symptoms at the beginning and end of each testing session. The LMEs revealed no 
significant differences in exhaled CO across the three nights [p = 0.49] and no significant 
differences in baseline negative affect across the three nights [p = 0.88]. Therefore, 
neither variable was included as a covariate in subsequent analyses.  
Finally, we conducted separate one-way ANOVAs to test for a significant effect 
of testing order on each of the outcome variables. That is, testing order was included as 
the independent variable, and separate ANOVAs were conducted with log10 transformed 
cortisol concentrations, AUCI, AUCG, and peak cortisol response to stress as the 
dependent variables. Testing order was significantly associated with log10 cortisol values 
[F(5, 301) = 10.861; p < 0.001] and peak cortisol response to stress [F(5, 40) = 2.527; p = 
0.04], as well as a small, but statistically non-significant effect on AUCG [p = 0.07; η
2 = 
0.231]. Additionally, there was a notable imbalance in the number of participants that 
were randomized to each testing order, with more than half of the sample assigned to 
complete the PASAT first (n = 9), three randomized to complete the stress imagery 
condition first, and four completing the neutral condition first. As such, we took the 
conservative approach and included task order as a covariate in all primary analyses.  
 
3.4 Test of primary study hypotheses 
3.4.1 Log10 Transformed Cortisol Values 
 To address the subhypotheses regarding the effects of the experimental tasks on 
log10 transformed cortisol values, a linear mixed effects model was implemented with 




Imagery) and Time (centered) (5 levels; immediately post-task, +10min, +20min, 
+30min, and +40min), as well as between subjects covariate factors of IVS scores, 
baseline cortisol concentrations, and testing order as fixed factors and subjects as the 
random factor. The analysis revealed no significant main effect of time [p = 0.26] or 
condition [p = 0.13], and no significant time by condition interaction [p = 0.11] on log10 
transformed cortisol values. See Figure 2 for a plot of the mean baseline cortisol values 
and the mean log10 transformed cortisol concentrations at each of the 5 post-task time 
points for each experimental condition. Estimates of fixed effects are listed in Table 3. 
 
3.4.2 Log10 Transformed Peak Cortisol Values  
 To address the subhypotheses regarding the effects of the experimental tasks on 
log10 transformed peak cortisol values, a linear mixed effects model was implemented 
with the within subjects factor of Condition (3 levels: PASAT, Stress Imagery, and 
Neutral Imagery), as well as between subjects covariate factors of IVS scores, baseline 
cortisol concentrations, and task order as fixed factors, and subjects as the random factor. 
The analysis revealed no significant effect of condition on peak cortisol values [p = 0.63]. 
See Table 4 for the estimates of fixed effects, and Figure 3 for a bar graph representing 
the adjusted mean log10 transformed peak cortisol values for each condition. 
 
3.4.3 Log10 Transformed AUCG 
To address the subhypotheses regarding the effects of the experimental tasks on 
log10 transformed AUC with respect to ground (AUCG) values, a linear mixed effects 




Stress Imagery, and Neutral Imagery), as well as between subjects covariate factors of 
IVS scores, baseline cortisol concentrations, and task order as fixed factors, and subjects 
as the random factor. The analysis revealed no significant effect of condition on AUCG 
values [p = 0.81]. See Table 5 for the estimates of fixed effects, and Figure 4 for a bar 
graph representing the adjusted mean log10 transformed AUCG values for each condition. 
 
3.4.4 Log10 Transformed AUCI 
To address the subhypotheses regarding the effects of the experimental tasks on 
log10 transformed AUC with respect to increase (AUCI) values, a linear mixed effects 
model was implemented with the within subjects factor of Condition (3 levels: PASAT, 
Stress Imagery, and Neutral Imagery), as well as between subjects covariate factors of 
IVS scores, baseline cortisol concentrations, and task order as fixed factors, and subjects 
as the random factor. The analysis revealed no significant effect of condition on AUCI 
values [p = 0.89]. See Table 6 for the estimates of fixed effects, and Figure 5 for a bar 
graph representing the adjusted mean AUCI values for each condition. 
 
3.4.5 Exploratory Analyses 
 Although the omnibus timeXcondition interaction effect that was reported in 
Section 3.4.1 was not statistically significant [p = 0.11], we conducted additional 
exploratory analyses of the effect of time on each of the three experimental conditions 
separately, in order to supplement our primary analyses and to more fully characterize the 
pattern of salivary cortisol response that was observed in response to each of the three 




experimental condition), with log10 transformed post-task cortisol concentrations serving 
as the dependent variables. The analyses included the within subjects factor of Time (5 
levels: immediately post-task, +10, +20, +30, and +40), as well as between subjects 
covariate factors of baseline cortisol concentrations and task order as fixed factors, and 
subjects as the random factor. IVS scores were only included as between subjects 
covariates in the LME analyses conducted for the two imagery conditions given that 
these were the only testing sessions in which IVS scores were collected. The LME 
analyses revealed no effect of time on log10 transformed cortisol values during the stress 
imagery condition [p = 0.60], a significant negative linear effect of time on log10 
transformed cortisol values during the PASAT condition [B = -0.03, SE = 0.01, p = 0.05], 
and an even stronger significant negative linear effect of time on log10 transformed 
cortisol values during the neutral condition [B = -0.04, SE = 0.02, p = 0.02]. See Tables 7, 





Chapter 4: Discussion 
4.1 Summary of Main Findings 
The current study examined the pattern of HPA axis response to two different 
previously validated psychological stressors compared to a neutral no-stress condition in 
a sample of 16 cocaine dependent individuals in residential substance use treatment. The 
current study built on previous work establishing dysregulated patterns of cortisol 
reactivity to psychological stress among cocaine dependent individuals (Daughters et al., 
2009; Harris et al., 2005; Lovallo et al., 2000; Sinha et al., 2003; 2006) by directly 
comparing the pattern of cortisol reactivity to two different psychological stressors, 
including: 1) a personalized stress imagery script (Sinha et al., unpublished manual) and 
2) a non-personalized computerized challenge task (i.e., PASAT; Lejuez et al., 2003), as 
compared to a neutral, no stress condition. Additionally, because there are different 
approaches that have been used across studies to analyze cortisol reactivity data, each of 
which captures slightly different aspects of the cortisol response to stress, the current 
study built on previous findings by utilizing three different methods of analyzing HPA 
axis response to the three experimental conditions. Specifically, we tested for: 1) 
differential change in salivary cortisol concentrations across the five post-task time points 
between the three conditions, 2) differences in peak salivary cortisol response to the three 
conditions, and 3) differences in AUC between the three conditions. Using all three 
approaches allowed for a potential examination of the reliability and robustness of any 
significant differences in cortisol response across the various analytic approaches. We 
hypothesized that all three approaches to analyzing the cortisol data would reveal: 1) a 




compared to the neutral imagery condition, 2) a greater salivary cortisol response to the 
PASAT as compared to the neutral imagery condition, and 3) a greater salivary cortisol 
response to the personalized stress imagery condition as compared to the non-
personalized PASAT condition. 
 In conducting the primary study analyses to test for differences in cortisol 
reactivity in response to the stress imagery script, the PASAT, and the neutral imagery 
script, no significant differences in cortisol response were found across the three 
experimental conditions. Specifically, after controlling for confounding variables, 
including testing order, baseline salivary cortisol concentrations, and differences in 
imagery vividness across the two personalized imagery conditions (i.e., stress imagery 
and neutral imagery), no significant differences were found in log10 transformed cortisol 
concentrations, peak cortisol response values, or AUC values across the three 
experimental conditions. The only analytical approach that came close to approaching a 
statistically significant difference on cortisol response between the three conditions was 
the assessment of change in log10 transformed salivary cortisol concentrations across the 
five post-task time points. Specifically, LME analyses revealed a non-significant time by 
condition interaction [p = 0.11]. Given that our small sample size may have precluded a 
significant omnibus interaction effect, we conducted additional exploratory analyses to 
assess the linear effect of time on salivary cortisol response for each condition separately. 
These analyses revealed a significant negative linear effect of time on cortisol 
concentrations during the PASAT condition and the neutral imagery condition, but no 




Although no definitive conclusions can be drawn on the basis of these exploratory 
findings given the absence of an omnibus interaction effect, the general pattern that was 
observed may suggest that under neutral, non-stressed laboratory conditions, the natural 
pattern of cortisol secretion among this sample is a linear decline over time; however, 
exposure to psychological stress may prevent this natural decline, keeping cortisol 
concentrations level over time rather than declining. Specifically, there was a non-
significant increase in negative affect during the PASAT condition, during which there 
was a less robust, but statistically significant, linear decline in cortisol concentrations 
over time as compared to the neutral condition.  Conversely, there was a significant 
increase in negative affect in response to the stress imagery script, and cortisol values 
showed no significant linear effect of time during the stress imagery condition. Although 
there was no significant difference in the overall pattern of cortisol secretion between the 
three conditions, the fact that cortisol concentrations dropped significantly over time 
during the neutral imagery condition, less so during the PASAT condition, and not at all 
during the stress imagery condition may suggest that exposure to psychological stress 
may function to mitigate the natural decline in cortisol that is observed among cocaine-
dependent individuals in the absence of stress. Importantly, these observed patterns and 
interpretations are highly speculative given that the omnibus timeXcondition interaction 
effect was not significant.  
 Although the sample size in the current study was quite small, the dearth of 
statistically significant differences in cortisol reactivity across the three experimental 
conditions was highly unexpected, especially given the methodological precautions that 




account for the lack of significant findings. First, there was a significant effect of testing 
order on log10 transformed cortisol concentrations and peak cortisol values. Although we 
covaried for testing order in all analyses, the imbalance in the number of participants that 
were randomized to each testing order (i.e., 9 participants completed the PASAT 
condition first, as compared to 3 who completed the stress imagery condition first and 4 
who completed the neutral imagery first) may have influenced the findings. 
 Another potential explanation for the current study’s lack of significant findings is 
the time of day that was chosen to conduct testing. While evening hours are ideal for 
controlling for the potentially confounding effects of the circadian decline in cortisol 
secretion that occurs during morning hours, there is some evidence in the literature that 
the HPA axis may be less reactive in the evening, particularly between the hours of 
6:00PM and 12:00AM (Horrocks et al., 1990). However, other researchers have found no 
evidence for reduced HPA axis reactivity to psychological stress in the late afternoon and 
early evening as compared to morning hours (Kudielka et al., 2004). Thus, it is possible 
that the lack of cortisol response to the psychological stressors in the current study may 
be explained by circadian influences on HPA axis reactivity, but the magnitude of the 
circadian effect on cortisol reactivity during evening hours remains unclear.   
The current study’s null findings may also imply that HPA axis response to 
psychological stress among cocaine dependent individuals is not as reliable and robust as 
the current literature suggests. This is not to say that our null findings present a direct 
challenge to conventional findings; however, the current results may suggest that 
clinicians should be cautious when interpreting findings in the extant literature and 




treatments that are specifically aimed at reducing HPA axis dysfunction. This need for 
caution is also exemplified by the fact that the current literature exhibits a great deal of 
methodological heterogeneity across studies, thus increasing the difficulty of generalizing 
findings and drawing firm conclusions. Moreover, given the multitude of mathematical 
(e.g, peak cortisol response, AUCG, AUCI, percent change from baseline, and mean 
cortisol concentrations) and statistical approaches (e.g., repeated measures ANOVAs, 
linear regression, linear mixed effects models, and growth curve modeling) that are 
currently in use when it comes to examining and testing patterns of cortisol reactivity, it 
is somewhat troubling that the analytic methods that are used vary widely across studies 
of HPA axis functioning, even when examining literature emanating from a single 
researcher or laboratory. That is, the absence of a standardized approach to examining 
cortisol functioning allows for researchers to use multiple mathematical and statistical 
approaches to examine their data and to report findings using any method that yields a p-
value of <.05, even if the other methods that were used showed no significant effect. As 
such, the accessibility and acceptability of a countless number of approaches to analyzing 
and reporting cortisol data may lead to an inflated risk of Type I error as a consequence 
of conducting multiple comparisons. The field could benefit greatly from an effort to 
standardize both experimental and statistical methods in order to clarify the specific 
conditions under which the HPA axis responds to stress, the reliability of HPA axis 
responding across methodological and statistical approaches, and the extent to which 
HPA axis reactivity to stress differs across different clinical and non-clinical samples.  
 Finally, it is also possible that the non-significant differences between cortisol 




reflection of the severe HPA axis dysfunction that has consistently been observed among 
cocaine dependent individuals. Indeed the impaired cortisol responses to stress that were 
observed in the current study are consistent with empirical (e.g., Daughters et al., 2009; 
Harris et al., 2005; Lovallo et al., 2000; Sinha et al., 1999, 2000, 2003) and theoretical 
evidence (Koob & LeMoal, 2008) suggesting that chronic substance use leads to 
allostatic changes in brain reward and anti-reward (i.e., stress) circuits, which are 
characterized by chronic elevation in basal HPA axis functioning and blunted HPA axis 
response to stress. Although Sinha and colleagues have consistently reported significant 
(albeit blunted) cortisol responses to stress compared to non-stressed conditions among 
cocaine users, our findings are consistent with Lovallo and colleague’s (2000) finding 
that only healthy control participants showed a significant effect of stress on cortisol 
functioning, whereas alcohol dependent and comorbid alcohol + stimulant dependent 
individuals showed no significant difference between the two conditions. Unfortunately, 
it is impossible to provide experimental support for this explanation in the current study 
given that we did not include a healthy control group of non-drug users to examine 
whether these patterns of cortisol non-reactivity to our psychological stress manipulations 
are specific to cocaine dependence, or if it could be explained by a failure of the 
experimental stress manipulations to induce a robust HPA axis response in all 
participants, regardless of substance use status. Importantly, the patterns of cortisol 
response that were observed when examining each of the experimental conditions 
separately may provide some evidence that Sinha and colleague’s stress imagery 
procedure did in fact influence cortisol secretion by holding the concentrations steady 




and more so in the neutral imagery condition. However, the non-significant omnibus 
interaction effect hinders our ability to conclusively interpret our data in this manner. 
 Overall, the small sample size and lack of a healthy control group leads to great 
difficulty in interpreting the nonsignificant findings reported in the current study. 
However, the general pattern of the data implies that there may be a natural linear decline 
in cortisol concentrations during the evening hours when individuals are not exposed to 
psychological stress (i.e., during the neutral imagery condition) and this linear decline 
may be reduced in the presence of a challenging working memory task (i.e., the PASAT) 
and may be completely eliminated in the presence of intense, personalized stressful 
imagery (i.e., the stress imagery condition). Future studies may determine whether this 
general pattern of cortisol functioning holds true among larger samples of chronic 
cocaine users as compared to matched samples of healthy control participants. 
4.2 Limitations and Future Directions 
 One limitation of the current study that is important to note is the modest sample 
size. It has been suggested that for linear mixed effects models, sample sizes of at least 20 
(and preferably 50) are most appropriate in order to obtain a level of statistical power that 
is adequate for detecting significant effects (Hox, 1995). It is worth noting, however, that 
the sample size in the current study is comparable to many of the within subjects design 
studies of cortisol reactivity among substance users that were described in Chapter 1. For 
example, Sinha and colleagues (1999) reported a significant difference in cortisol 
response to a personalized stress imagery script compared to a neutral script in a sample 
of only ten cocaine users, and Lovallo and colleagues (2000) included only twelve 




neutral condition among healthy controls, alcohol users, and comorbid alcohol and 
stimulant users, finding a significant effect of testing condition among healthy controls 
only. An estimate of effect size would be useful for determining whether there was a 
robust effect of psychological stress on cortisol functioning in the current study that 
simply failed to reach statistical significance; however, effect size estimation for mixed 
linear models is complicated given that both the fixed and random effects in the model 
must be estimated (Field, 2009). Moreover, few statistical software packages currently 
provide effect size calculators for mixed effects models. As such, it remains unclear if our 
non-significant findings may be explained by low statistical power due to the small 
sample size. 
A second limitation of the current study is the absence of a significant increase in 
self-reported distress, as measured by the negative affect scale of the PANAS, following 
PASAT administration.  Although the increase in distress that was exhibited in response 
to the PASAT administration did not reach significance at the 0.05 level, the small 
sample size may not have provided enough statistical power to detect a significant effect. 
Thus, we also examined the effect size of PASAT administration on change in distress 
ratings and found an effect size that was small, but generally considered significant 
within social science research (partial η2 = 0.205) (Cohen, 1988; 1992). Additionally, we 
examined ratings on individual items of the PANAS negative affect scale and found 
significant increases on some items, including “Distress” and “Upset”, but no significant 
increase in ratings of other items in the negative affect scale, including “Irritable”, 
“Guilty”, “Scared”, “Hostile”, “Ashamed”, “Nervous”, “Jittery”, and “Afraid”. As such, 




including feeling distressed and upset, as opposed to the personalized stress imagery 
script which effectively induced a more general negative affective state. 
The current study is also limited given that participants were exposed to the 
PASAT during their baseline assessment session, thus reducing the novelty of the task 
when it was administered for the second time during the PASAT cortisol testing session. 
Given that novelty is one factor that has been associated with the magnitude of the HPA 
axis response to stress (Dickerson & Kemeny, 2004), exposure to the PASAT during 
baseline screening may have influenced the pattern of cortisol response that was observed 
in response to the PASAT during cortisol testing. It is possible that repeated exposures to 
the PASAT may have also mitigated the negative affective response to the task upon 
completing it a second time, thus explaining the non-significant increase in negative 
affect ratings that were observed following PASAT administration during cortisol testing. 
Another limitation of the current study is the significant difference in baseline 
“pre-stress” cortisol concentrations, such that participants exhibited significantly greater 
baseline cortisol during the neutral imagery condition as compared to the PASAT and 
stress imagery conditions. It is unclear what drove this difference in baseline salivary 
cortisol values; however, it is possible that an unknown confounding variable induced an 
elevation in cortisol secretion immediately prior to the neutral condition, but not the other 
two testing sessions. One possible explanation is that individuals were more nervous 
when they arrived for the neutral imagery sessions than they were at the beginning of the 
other two conditions due to the imbalance in testing order assignment. That is, the 
majority of participants were randomized to complete at least one of the two stress 




triggering an anticipatory cortisol response upon returning to the laboratory setting 
following stress administration on a previous testing night. Despite the plausibility of this 
explanation, there was no significant relationship between testing order and baseline 
salivary cortisol values, and there was no significant difference in self-reported negative 
affect at baseline during the neutral imagery condition compared to the two stress 
conditions. Alternatively, it is possible that there may have been an unknown 
experimenter effect that influenced cortisol secretion at baseline during the neutral 
condition. For example, perhaps research assistants spent less time administering the 
progressive relaxation exercise during neutral imagery sessions compared to the other 
two conditions. Unlike experiments conducted by Sinha and colleagues, research 
assistants in the current study were not blinded to the experimental condition on each 
testing night; therefore, the possibility of an experimenter effect on baseline cortisol 
secretion cannot be discounted.  
Finally, the current study is limited in the extent to which findings can be 
generalized across other samples of cocaine users. Specifically, the current study 
excluded women, individuals with comorbid opiate dependence and/or Axis I 
psychopathology, individuals on certain medications, and individuals with major medical 
conditions. Given the small number of participants that met inclusion criteria over the 
course of 16 months of study recruitment, it is clear that the current study sample is not 
representative of the overall population of substance users at the recruitment facility. 
Additionally, there is mixed evidence in the literature to suggest that some environmental 
factors, such as low socioeconomic status (Cohen, Doyle, & Baum, 2006; Cohen, 




for review see Dowd, Simanek, & Aiello, 2009), racial discrimination and race-related 
stress (Pascoe & Richman, 2009; Richman & Jonassaint, 2008; Tull, Shue, Butler, & 
Cornelious, 2005), and chronic stress exposure (Miller, Chen, & Zhou; Wolf, Nicholls, & 
Chen, 2008; Zarcovic et al., 2003) are associated with HPA axis abnormalities. Given 
that the current sample consisted of primarily low-income African American individuals 
living in or near the inner-city, all of these factors are likely to have had a significant 
effect on the pattern of cortisol reactivity to stress that was observed in our particular 
sample, thus reducing the generalizability of our findings even further. 
Many questions remain in the field of HPA axis functioning and addiction. 
Additional research is needed to increase our understanding of the specific conditions 
under which drug dependent individuals exhibit abnormal cortisol reactivity to stress, and 
the extent to which cortisol reactivity to different types of stress is associated with 
differential vulnerability for stress-induced relapse. Larger scale studies that include 
matched samples of healthy non-drug users are needed to facilitate the further 
development of larger models that include individual difference factors, such as specific 
genetic polymorphisms, early and chronic stress exposure, gender, and personality factors 
that may influence both basal HPA axis functioning and reactivity to stress. It is possible 
that larger models of this kind may be useful for identifying individuals who are most 
susceptible to stress-related neuroadaptations over the course of addiction, as well as 
those most susceptible to stress-induced relapse. Such research could be of clinical 
benefit both in the assessment of relapse susceptibility and potentially by matching 




interventions that are specific to these addictive processes (Sinha, 2009). However, a 




Table i. Demographic Information 
Demographic Characteristic   
Age, mean (SD) 46.44 (7.05)  
Marital Status   
     Single, %   75.0  
     Living with a partner as if married, %   12.5  
     Married but separated, %   6.25  
     Married, %   6.25  
Race   
     Black, %   100.0  
Education   
     Less than high school, %   25.0  
     High School/GED, %   43.75  
     More than high school, %   21.25  
Total Income < 10,000, %   56.25  
Unemployed, %   43.75  









PASAT 11.88 (3.12) 15.13 (6.30) 
Stress Imagery** 11.34 (2.03) 21.63 (11.63) 
Neutral Imagery 11.88 (4.16) 11.88 (3.69) 




Table iii. LME analysis predicting log10 transformed cortisol concentrations  
    Variable B SE   T   P   95% CI 
Fixed effects      
  Testing Order -.02 .02 -.88 .40 [-.07, .03] 
  Baseline Cortisol .90 .08 11.23 <.001 [.74, 1.06] 
  Imagery Vividness .01 .03 .39 .70 [-.05, .07] 
  Time (centered) .07 .06 1.12 .26 [-.05, .18] 
  Condition .09 .06 1.54 .13 [-.03, .21] 





Table iv. LME analysis predicting log10 transformed peak cortisol values  
      Variable B SE T P 95% CI 
Fixed effects      
  Testing Order -.03 .06 -.48 .63 [-.15, .09] 
  Baseline Cortisol .53 .26 2.08 .05 [.01, 1.05] 
  Imagery Vividness .00 .10 .02 .99 [-.20, .20] 






Table v. LME analysis predicting log10 transformed AUCG values  
      Variable B SE T P 95% CI 
Fixed effects      
  Randomization -.02 .02 -.94 .35 [-.06, .01] 
  Baseline Cortisol 1.00 .07 13.70 <.001 [.86, 1.15] 
  Imagery Vividness .02 .03 .61 .54 [-.04, .07] 






Table vi. LME analysis predicting log10 transformed AUCI values  
      Variable B SE T P 95% CI 
Fixed effects      
  Randomization .01 .03 .34 .74 [-.05, .07] 
  Baseline Cortisol -.03 .11 -.24 .81 [-.26, .20] 
  Imagery Vividness .00 .04 .01 .99 [-.09, .09] 






Table vii. LME analysis predicting log10 transformed cortisol values during PASAT 
condition 
      Variable B SE T P 95% CI 
Fixed effects      
  Randomization .00 .02 -.025 .98 [-.04, .04] 
  Baseline Cortisol 1.04 .09 11.23 <.001 [.85, 1.24] 





Table viii. LME analysis predicting log10 transformed cortisol values during stress 
imagery condition 
      Variable B SE T P 95% CI 
Fixed effects      
  Randomization .02 .03 .70 .50 [-.04, .08] 
  Baseline Cortisol 1.22 .17 7.24 <.001 [.87, 1.58] 
  Imagery Vividness .02 .05 .45 .66 [-.09, .14] 





Table iv. LME analysis predicting log10 transformed cortisol values during neutral 
imagery condition 
      Variable B SE T P 95% CI 
Fixed effects      
  Randomization -.04 .02 -2.36 .03 [-.08, .00] 
  Baseline Cortisol 1.11 .07 14.80 <.001 [.95, 1.27] 
  Imagery Vividness .01 .03 .34 .74 [-.05, .07] 





Figure i. Diagram of Testing Session Procedures 
 
Testing Sessions 
                                    
            Relax  Rest  Task                  Rest   
 
                      |         |         |         |         |         |         |         |         |         |  
(minutes)    -30    -20     -10      0       10      20      30      40      50     60         
                             (C1)   (C2)  (C3)   (C4)   (C5)  (C6)   (C7)    
 
                                    BL      
 
 
Relax = Relaxation Procedures 
C = Cortisol 
BL = Baseline cortisol samples for each task (mean of the first two “pre-stress samples) 












Figure iii. Plot of mean log10 transformed salivary cortisol concentrations at each time 
point by condition. Dotted line reflects experimental task administration. Baseline values 





































































Appendix I: Sample Stress Imagery Script 
“Close your eyes and imagine the scene as if it were happening right now. When the 
scene is over, continue imagining until I tell you to stop. Let’s begin.” 
 
It is a warm evening in May. You are watching television in the living room of your 
mother’s old home in D.C. [Your sister]* walks through the front door of the house. Your 
heart quickens. She stands in the doorway and looks around the room. You scan her face 
with your eyes. You know she is about to pick a fight with you. You tense the muscles in 
your face and forehead. She shakes her head and turns to speak to you. “You need to 
think about finding a new place to live and get out of here”, she says. She sounds angry. 
‘What is she talking about?’, you think. You breathe faster. “Who the hell do you think 
you are? This isn’t your house!”, you yell. You tense the muscles in your back, arms, and 
legs. “This isn’t your house either”, she snaps back. “I can only imagine what Mom 
would say if she saw this place.” Your hands are trembling. ‘Who is she to tell me what 
our mother would want?’ Your heart is racing. ‘I’m the one that cared for Mom when she 
was dying’, you think. You breathe faster. Your whole body is shaking. [Your sister] is 
yelling at you. “This place is disgusting! You can’t even get yourself up to mow the 
damn lawn!” She screams. You clench your fists. You can’t believe your own sister is 
treating you like this. You want to scream or smash something. ‘Who does she think 
she’s talking to?’ you think. Your heart is pounding now. “It’s none of your damn 
business what I do with this house!” you shout back. Your stomach is in a knot. How 
could she just storm in like this? You want to throw her out of the house. “The hell it isn’t 
my business! [Your brother] and I both want you out”. You feel hot all over. How could 
they team up on me like this, you think? “So this is how it’s going to be?” you yell. 
“Well, you two will have to take me to court if you want me out of this place.” You grit 
your teeth. My own family is turning against me, and [my brother] wasn’t even man 
enough to tell me to my face. You feel jittery all over. “Fine!” [Your sister] shouts. “I’ll 
see you in court!” she screams. There is a sinking feeling in your stomach. She walks out 
the front door and slams it behind her. “Fuck you!” you yell. Your entire body is shaking. 
You start to go after her, but you stop yourself. You are so angry you could strike 
somebody. How could my own family gang up on me like this?? Where will I go if they 
kick me out? You imagine yourself on the street alone, homeless. There is a heavy 
feeling in your stomach. You feel helpless and betrayed.  You just want to get away, 
away from here and all of these terrible feelings. You feel empty, drained, hollow. It 
hurts to be alive. Tears come to your eyes. 
 
“You can stop imagining now. Please open your eyes and remove your headphones.” 
 





Appendix II: Sample Neutral Imagery Script  
“Close your eyes and imagine the scene as if it were happening right now. When the 
scene is over, continue imagining until I tell you to stop. Let’s begin.” 
 
It is 12 o’clock in the afternoon on a pleasant day in May. You are laying on the couch in 
the living room. You are alone and the house is quiet. Your stomach is full from the food 
you cooked this morning. You take in a deep breath as you lie back on the couch, 
stretching the muscles in your back and legs. When you listen closely, you can hear the 
hum of the air conditioning cooling the house. You reach down and pull a blanket over 
you, feeling warm and comfortable. Your breathing slows down. You move around to get 
comfortable, noticing the smooth, soft feel of the couch against your skin. You relax the 
muscles in your neck and shoulders as you lay your head down on the pillows. You feel 
the tension begin to melt out of your body. You stretch over and reach for the remote 
control to change the channel. You watch the bright images moving on the television set. 
The house is quiet and calming. You breathe in deeply and stretch the muscles in your 
arms, back and legs. You settle in and sink back into the couch. You notice that your 
clothing feels smooth and soft against your skin. You look down and notice Yodi sitting 
next to you on the floor. You turn your head to the side, slowly stretching the muscles in 
your neck. You slowly reach down and pet Yodi, feeling the soft fur in your hands. You 
feel the tension ease out of your body. You pull your arm back under the blanket as you 
snuggle more deeply into the couch.  Your heart beats slower. You take in a few more 
deep breaths, noticing the faint smell of fried potatoes, bacon, and eggs in the air. You 
exhale slowly, letting out any tension remaining in your body. The tension from your 
body goes away and you feel comfortable and at ease. You feel at peace in the quite 
solitude of the house. All of your worries fade away. You feel a general sense of release. 
Your breathing slows down. Slowly you find your eyes closing and your mind drifts 
away. There is a sense of lightness inside you. You want to hold time and capture this 
moment. A feeling of peace comes over you. 
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